跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 82 条关于
“Remepy”
全部
82
临床试验
59
药物
5
机构
4
资讯
14
4个月前
Merck KGaA Partners with Remepy to Pioneer "Hybrid Drugs" Combining Pharmaceuticals with Digital Therapeutics
去年
Remedy Plan Therapeutics Secures $18 Million to Advance Novel NAMPT Inhibitor for AML and MDS Treatment
去年
Remedy Plan Therapeutics Initiates Phase 1 Trial of First-in-Class NAMPT Inhibitor RPT1G
去年
Remedy Pharmaceuticals to Present CIRARA Data from Phase 3 CHARM Study at ISC 2025
5个月前
Remedy Plan Therapeutics Strengthens Leadership with Appointment of Jotin Marango as CFO and CBO
10个月前
Remedy Plan Therapeutics Achieves Breakthrough with First Safe NAMPT Inhibitor RPT1G for Blood Cancers
9个月前
Pluri Expands Manufacturing Partnership with Remedy Cell, Achieves Clinical-Grade Production for Fibrotic Disease Therapy
去年
Bioretec Expands U.S. Distribution of RemeOs Bioresorbable Orthopedic Implants
9个月前
Bioretec Receives FDA Breakthrough Device Designation for Biodegradable RemeOs DrillPin
去年
DiaMedica Announces ReMEDy2 Trial Updates and Q3 2024 Financial Results
第 1 页,共 2 页
上一页
下一页